A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01182025 |
Recruitment Status
: Unknown
Verified August 2010 by The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine.
Recruitment status was: Recruiting
First Posted
: August 16, 2010
Last Update Posted
: August 17, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hand, Foot and Mouth Disease | Other: Western therapy Drug: Xiyanping Injection Drug: Xiyanping Injection with western medicine | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 360 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Study Start Date : | June 2010 |
Estimated Primary Completion Date : | May 2011 |
Estimated Study Completion Date : | December 2011 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Western therapy |
Other: Western therapy
Symptomatic treatment: vitamin B, vitamin C, mouth care and skin care.
|
Experimental: Xiyanping Injection |
Drug: Xiyanping Injection
Dosage for child medication: 5-10mg/kg/d (0.2-0.4ml/kg/d) in 5% Glucose solution, IV, with speed of 20-30 drops per minute, each day; or as directed by doctor. |
Experimental: Xiyanping Injection with western medicine |
Drug: Xiyanping Injection with western medicine
|
- time of bringing down the fever [ Time Frame: 10 days ]Refering to the length of time to bring down the fever by 0.5 degrees Celsius after the medicine is taken.
- time of body temperature going back to normal [ Time Frame: 10 days ]Refering to the time of the armpit temperature of lower than 37.0 degrees Celsius, lasting for at least 24 hours, after the medicine is taken.
- time of symptom disappearance [ Time Frame: 10 days ]Refering to the length of time when clinical symptoms and signs totally disappere after the medicine is used.
- case severity rate [ Time Frame: 10 days ]Refering to the ratio of patient with mild type of HFMD to severe type, such as damage of central nervous system, pulmonary edema, heart failure, respiratory failure, etc.
- time of tetter disappearance [ Time Frame: 10 days ]Refering to the length of time when the tetter due to HFMD disappears, characterised by scab(s) or dropping; and time of oral ulcer concrescence, etc.
- direct medical cost [ Time Frame: 10 days ]Referring to the costs in the treatment of HFMD and relative disease, including the registration fee, examination fee, and drug fees, etc.
- safety outcome [ Time Frame: 10 days ]Calculated by adverse event.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year to 14 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Clinical diagnosis of severe hand-foot-mouth disease patients according to Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of Health; More than 1/3 patients should be diagnosed by etiological examination.
- Less than 48 hours of occurrence of fever and/or occurrence of tetter or herpes.
- Age of 1-14 years.
- Patients or their guardians agree to participate in this study and signed the informed consent form.
Exclusion Criteria:
- Complicated with other serious primary diseases in organ such as congenital heart disease, chronic hepatitis, nephritis and blood diseases, etc.
- With history of allergies on traditional Chinese medicine.
- Patients or their guardians suffering from Psychiatric diseases.
- Attending other clinical studies on HFMD after diagnosed.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01182025
China, Guangxi | |
Affiliated Hospital of Guilin Medical College | Recruiting |
Guilin, Guangxi, China, 541001 | |
Contact: Xiong Li 13737728526 yuanyanhui_888@163.com | |
Principal Investigator: Xiong Li | |
Liuzhou Worker's Hospital | Recruiting |
Liuzhou, Guangxi, China, 541001 | |
Contact: Liuping Tang 18977228768 yongren126zeng@126.com | |
Contact: Zhe Guo 13978009767 sdy761212@163.com | |
Principal Investigator: Liuping Tang | |
Principal Investigator: Zhe Guo | |
Liuzhou People's Hospital | Recruiting |
Liuzhou, Guangxi, China, 545001 | |
Contact: Tong Yang 13977286628 zhoubing-1995@163.com | |
Principal Investigator: Tong Yang | |
China, Guangzhou | |
Shenzhen Maternity & Child Healthcare Hospital | Recruiting |
Shenzhen, Guangzhou, China, 518028 | |
Contact: Xinying Zou 13129559135 Xuzhiymr@yahoo.com.cn | |
Principal Investigator: Xinying Zou | |
China, Jiangxi | |
Jiangxi Provincial Children's Hospital | Recruiting |
Nanchang, Jiangxi, China, 330006 | |
Contact: Qingxiong Zhu 15979003000 Zhuqingxiong2000@163.com | |
Principal Investigator: Qingxiong Zhu |
Principal Investigator: | Guoliang Zhang | An'Hui Chinese Medical College Affiliated No.1 Hospital |
Responsible Party: | Guoliang Zhang, The First Affiliated Hospital of Anhui College of Traditional Chinese Medicine |
ClinicalTrials.gov Identifier: | NCT01182025 History of Changes |
Other Study ID Numbers: |
200907001-4 |
First Posted: | August 16, 2010 Key Record Dates |
Last Update Posted: | August 17, 2010 |
Last Verified: | August 2010 |
Keywords provided by The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine:
Mild type of hand, foot and mouth disease Xiyanping Injection Effectiveness Safety |
Additional relevant MeSH terms:
Mouth Diseases Foot-and-Mouth Disease Hand, Foot and Mouth Disease Stomatognathic Diseases Picornaviridae Infections |
RNA Virus Infections Virus Diseases Coxsackievirus Infections Enterovirus Infections |